CDH1 and breast lobular carcinoma: In contrast, the risk of GC in patients with CDH1 germline mutations is reported to be 70% in men, 56% in women, and 42% in women with lobular breast carcinoma by the age of 80 years,6 indicating a significantly higher incidence of GC than that of other hereditary diseases.